高级检索
当前位置: 首页 > 详情页

Crystallization and characterization of small molecular multidrug resistance inhibitor targeting P-glycoprotein, NSC23925 isomers

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ EI

单位: [1]Department of Clinical Laboratory Diagnostics, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China [2]Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA [3]Department of Obstetrics and Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, 201204, China [4]Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138, USA
出处:
ISSN:

关键词: Multidrug resistance (MDR) P-glycoprotein (Pgp) NSC23925 Stereoisomer Crystal structure

摘要:
The correlation between P-glycoprotein (Pgp) overexpression and multidrug resistance (MDR) in cancer is well-established. Recently, we identified (2-(4-methoxyphenyl)-4-quinolinyl) (2-piperidinyl)methanol (5) (NSC23925) as the most selective and potent MDR inhibitor. NSC23925 binds to Pgp, thus inhibiting its transporter function and reversing MDR in cancer cells. In order to further characterize the chemical properties and Pgp binding mode of the NSC23925 compound, we grew four NSC23925 crystal isomers (NSC23925a, NSC23925b, NSC23925c, and NSC23925d). These crystal isomers were first generated using a vapor diffusion growth technique before their precise structures were analyzed using X-ray crystal-lography. Functionally, the NSC23925a and NSC23925b isomers share a similar stabilization interaction of Cl- mediated hydrogen bonding. In contrast, in isomer NSC23925c, two Cl- are involved in the stabilization of adjacent molecules. In summary, these solved crystal structures may reveal the different activities of the four NSC23925 stereoisomers. (C) 2019 Elsevier B.V. All rights reserved.

基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 4 区 化学
小类 | 4 区 物理化学
最新[2025]版:
大类 | 2 区 化学
小类 | 2 区 物理化学
JCR分区:
出版当年[2017]版:
Q3 CHEMISTRY, PHYSICAL
最新[2023]版:
Q2 CHEMISTRY, PHYSICAL

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2017版] 出版当年五年平均[2013-2017] 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者单位: [1]Department of Clinical Laboratory Diagnostics, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China [2]Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)